| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.069 | 14.532 | 15.014 | 16.613 | 17.764 | 17.034 | 17.322 | 20.589 | 23.154 | 18.929 |
| Total Income - EUR | 14.069 | 14.533 | 15.014 | 16.613 | 17.765 | 17.046 | 17.323 | 20.589 | 23.155 | 18.929 |
| Total Expenses - EUR | 10.049 | 14.233 | 14.131 | 14.014 | 12.994 | 17.006 | 19.157 | 20.254 | 21.869 | 20.879 |
| Gross Profit/Loss - EUR | 4.020 | 300 | 883 | 2.599 | 4.771 | 40 | -1.834 | 336 | 1.285 | -1.949 |
| Net Profit/Loss - EUR | 3.598 | 116 | 733 | 2.433 | 4.593 | -130 | -2.004 | 134 | 1.058 | -2.506 |
| Employees | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Neurologie Dr.ghimiş S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.539 | 1.496 | 2.182 | 3.967 | 6.084 | 7.519 | 9.062 | 12.720 | 21.094 | 6.738 |
| Inventories | 0 | 0 | 354 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 464 | 576 | 196 | 546 | 923 | 688 | 1.235 | 934 | 1.121 | 0 |
| Cash | 4.075 | 920 | 1.632 | 3.422 | 5.161 | 6.831 | 7.827 | 11.785 | 19.973 | 6.738 |
| Shareholders Funds | 3.652 | 170 | 900 | 2.485 | 4.643 | 4.425 | 2.323 | 2.464 | 3.515 | 989 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 906 | 1.326 | 1.282 | 1.483 | 1.441 | 3.094 | 6.739 | 10.256 | 17.579 | 5.749 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurologie Dr.ghimiş S.r.l.